Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.25 | 3e-14 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-12 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-09 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-08 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-07 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-07 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |